135 related articles for article (PubMed ID: 17065663)
1. The involvement of upstream stimulatory factor 1 in Dutch patients with familial combined hyperlipidemia.
van der Vleuten GM; Isaacs A; Hijmans A; van Duijn CM; Stalenhoef AF; de Graaf J
J Lipid Res; 2007 Jan; 48(1):193-200. PubMed ID: 17065663
[TBL] [Abstract][Full Text] [Related]
2. Upstream stimulatory factor 1 associated with familial combined hyperlipidemia, LDL cholesterol, and triglycerides.
Coon H; Xin Y; Hopkins PN; Cawthon RM; Hasstedt SJ; Hunt SC
Hum Genet; 2005 Sep; 117(5):444-51. PubMed ID: 15959806
[TBL] [Abstract][Full Text] [Related]
3. Association of USF1 and APOA5 polymorphisms with familial combined hyperlipidemia in an Italian population.
Di Taranto MD; Staiano A; D'Agostino MN; D'Angelo A; Bloise E; Morgante A; Marotta G; Gentile M; Rubba P; Fortunato G
Mol Cell Probes; 2015 Feb; 29(1):19-24. PubMed ID: 25308402
[TBL] [Abstract][Full Text] [Related]
4. Upstream transcription factor 1 gene polymorphisms are associated with high antilipolytic insulin sensitivity and show gene-gene interactions.
Kantartzis K; Fritsche A; Machicao F; Stumvoll M; Machann J; Schick F; Häring HU; Stefan N
J Mol Med (Berl); 2007 Jan; 85(1):55-61. PubMed ID: 17016691
[TBL] [Abstract][Full Text] [Related]
5. Haplotype analyses of the APOA5 gene in patients with familial combined hyperlipidemia.
van der Vleuten GM; Isaacs A; Zeng WW; ter Avest E; Talmud PJ; Dallinga-Thie GM; van Duijn CM; Stalenhoef AF; de Graaf J
Biochim Biophys Acta; 2007 Jan; 1772(1):81-8. PubMed ID: 17157483
[TBL] [Abstract][Full Text] [Related]
6. Association of the APOLIPOPROTEIN A1/C3/A4/A5 gene cluster with triglyceride levels and LDL particle size in familial combined hyperlipidemia.
Mar R; Pajukanta P; Allayee H; Groenendijk M; Dallinga-Thie G; Krauss RM; Sinsheimer JS; Cantor RM; de Bruin TW; Lusis AJ
Circ Res; 2004 Apr; 94(7):993-9. PubMed ID: 15001527
[TBL] [Abstract][Full Text] [Related]
7. USF1 contributes to high serum lipid levels in Dutch FCHL families and U.S. whites with coronary artery disease.
Lee JC; Weissglas-Volkov D; Kyttälä M; Sinsheimer JS; Jokiaho A; de Bruin TW; Lusis AJ; Brennan ML; van Greevenbroek MM; van der Kallen CJ; Hazen SL; Pajukanta P
Arterioscler Thromb Vasc Biol; 2007 Oct; 27(10):2222-7. PubMed ID: 17673701
[TBL] [Abstract][Full Text] [Related]
8. Potential role of upstream stimulatory factor 1 gene variant in familial combined hyperlipidemia and related disorders.
Auer S; Hahne P; Soyal SM; Felder T; Miller K; Paulmichl M; Krempler F; Oberkofler H; Patsch W
Arterioscler Thromb Vasc Biol; 2012 Jun; 32(6):1535-44. PubMed ID: 22460558
[TBL] [Abstract][Full Text] [Related]
9. Familial combined hyperlipidemia in Mexicans: association with upstream transcription factor 1 and linkage on chromosome 16q24.1.
Huertas-Vazquez A; Aguilar-Salinas C; Lusis AJ; Cantor RM; Canizales-Quinteros S; Lee JC; Mariana-Nuñez L; Riba-Ramirez RM; Jokiaho A; Tusie-Luna T; Pajukanta P
Arterioscler Thromb Vasc Biol; 2005 Sep; 25(9):1985-91. PubMed ID: 15976322
[TBL] [Abstract][Full Text] [Related]
10. Nomogram to diagnose familial combined hyperlipidemia on the basis of results of a 5-year follow-up study.
Veerkamp MJ; de Graaf J; Hendriks JC; Demacker PN; Stalenhoef AF
Circulation; 2004 Jun; 109(24):2980-5. PubMed ID: 15184285
[TBL] [Abstract][Full Text] [Related]
11. Diagnosis of familial combined hyperlipidemia based on lipid phenotype expression in 32 families: results of a 5-year follow-up study.
Veerkamp MJ; de Graaf J; Bredie SJ; Hendriks JC; Demacker PN; Stalenhoef AF
Arterioscler Thromb Vasc Biol; 2002 Feb; 22(2):274-82. PubMed ID: 11834528
[TBL] [Abstract][Full Text] [Related]
12. Segregation analysis of plasma apolipoprotein B levels in familial combined hyperlipidemia.
Bredie SJ; van Drongelen J; Kiemeney LA; Demacker PN; Beaty TH; Stalenhoef AF
Arterioscler Thromb Vasc Biol; 1997 May; 17(5):834-40. PubMed ID: 9157945
[TBL] [Abstract][Full Text] [Related]
13. A common genetic mechanism determines plasma apolipoprotein B levels and dense LDL subfraction distribution in familial combined hyperlipidemia.
Juo SH; Bredie SJ; Kiemeney LA; Demacker PN; Stalenhoef AF
Am J Hum Genet; 1998 Aug; 63(2):586-94. PubMed ID: 9683593
[TBL] [Abstract][Full Text] [Related]
14. Small and dense LDL in familial combined hyperlipidemia and N291S polymorphism of the lipoprotein lipase gene.
López-Ruiz A; Jarabo MM; Martínez-Triguero ML; Morales-Suárez-Varela M; Solá E; Bañuls C; Casado M; Hernández-Mijares A
Lipids Health Dis; 2009 Mar; 8():12. PubMed ID: 19335919
[TBL] [Abstract][Full Text] [Related]
15. USF1 gene variants, cardiovascular risk, and mortality in European Americans: analysis of two US cohort studies.
Reiner AP; Carlson CS; Jenny NS; Durda JP; Siscovick DS; Nickerson DA; Tracy RP
Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2736-42. PubMed ID: 17885212
[TBL] [Abstract][Full Text] [Related]
16. Association of plasma lipids and apolipoproteins with the insulin response element in the apoC-III promoter region in familial combined hyperlipidemia.
Groenendijk M; Cantor RM; Blom NH; Rotter JI; de Bruin TW; Dallinga-Thie GM
J Lipid Res; 1999 Jun; 40(6):1036-44. PubMed ID: 10357835
[TBL] [Abstract][Full Text] [Related]
17. Genetics of familial combined hyperlipidemia.
Naukkarinen J; Ehnholm C; Peltonen L
Curr Opin Lipidol; 2006 Jun; 17(3):285-90. PubMed ID: 16680034
[TBL] [Abstract][Full Text] [Related]
18. The Contribution of GWAS Loci in Familial Dyslipidemias.
Ripatti P; Rämö JT; Söderlund S; Surakka I; Matikainen N; Pirinen M; Pajukanta P; Sarin AP; Service SK; Laurila PP; Ehnholm C; Salomaa V; Wilson RK; Palotie A; Freimer NB; Taskinen MR; Ripatti S
PLoS Genet; 2016 May; 12(5):e1006078. PubMed ID: 27227539
[TBL] [Abstract][Full Text] [Related]
19. Upstream transcription factor-1 gene polymorphism is associated with increased adipocyte lipolysis.
Hoffstedt J; Rydén M; Wahrenberg H; van Harmelen V; Arner P
J Clin Endocrinol Metab; 2005 Sep; 90(9):5356-60. PubMed ID: 15985485
[TBL] [Abstract][Full Text] [Related]
20. Contribution of the hepatic lipase gene to the atherogenic lipoprotein phenotype in familial combined hyperlipidemia.
Allayee H; Dominguez KM; Aouizerat BE; Krauss RM; Rotter JI; Lu J; Cantor RM; de Bruin TW; Lusis AJ
J Lipid Res; 2000 Feb; 41(2):245-52. PubMed ID: 10681408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
